Quarterly report · Q1

Period2023-07-01 → 2023-09-30
Filed2023-11-13
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
MetricValuePeriodScopeSource row
Revenue¥1.1bn2023-07-01 → 2023-09-30Cons.Net sales
Revenue¥8.1bn2022-07-01 → 2023-06-30Cons.Net sales (5-year summary)
Revenue¥2.2bn2022-07-01 → 2022-09-30Cons.Net sales
Operating income−¥501m2023-07-01 → 2023-09-30Cons.Operating income
Operating income¥46m2022-07-01 → 2022-09-30Cons.Operating income
Ordinary income−¥496m2023-07-01 → 2023-09-30Cons.Ordinary income
Ordinary income¥727m2022-07-01 → 2023-06-30Cons.Ordinary income loss (5-year summary)
Ordinary income¥46m2022-07-01 → 2022-09-30Cons.Ordinary income
Profit before tax−¥497m2023-07-01 → 2023-09-30Cons.Income before income taxes
Profit before tax¥46m2022-07-01 → 2022-09-30Cons.Income before income taxes
Net income (owners)−¥527m2023-07-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥452m2022-07-01 → 2023-06-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥14m2022-07-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income−¥528m2023-07-01 → 2023-09-30Cons.Profit loss
Net income¥16m2022-07-01 → 2022-09-30Cons.Profit loss
Total assets¥7.4bnat 2023-09-30Cons.Assets
Total assets¥8.2bnat 2023-06-30Cons.Assets
Total assets¥7.9bnat 2022-09-30Cons.Total assets (5-year summary)
Total liabilities¥902mat 2023-09-30Cons.Liabilities
Total liabilities¥1.1bnat 2023-06-30Cons.Liabilities
Net assets / equity¥6.5bnat 2023-09-30Cons.Net assets
Net assets / equity¥7.2bnat 2023-06-30Cons.Net assets
Net assets / equity¥6.7bnat 2022-09-30Cons.Net assets (5-year summary)
Cash and deposits¥5.1bnat 2023-09-30Cons.Cash and deposits
Cash and deposits¥5.9bnat 2023-06-30Cons.Cash and deposits
EPS (basic)¥-20.152023-07-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥17.272022-07-01 → 2023-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥0.532022-07-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio85.1%at 2023-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio84.6%at 2023-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio82.8%at 2022-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 46
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-07-01 → 2023-09-30−¥3m
Reconciling Itemsreconcilingrevenue external2023-07-01 → 2023-09-30¥600,000
Reconciling Itemsreconcilingrevenue intersegment2023-07-01 → 2023-09-30−¥4m
Reconciling Itemsreconcilingsegment profit2023-07-01 → 2023-09-30−¥78m
jpcrp040300-q1r_E05367-000Clinical Evidence Servicereportable segmentrevenue2023-07-01 → 2023-09-30¥57m
jpcrp040300-q1r_E05367-000Clinical Evidence Servicereportable segmentrevenue external2023-07-01 → 2023-09-30¥57m
jpcrp040300-q1r_E05367-000Clinical Evidence Servicereportable segmentsegment profit2023-07-01 → 2023-09-30−¥11m
jpcrp040300-q1r_E05367-000Functional Cosmetic Retailingreportable segmentrevenue2023-07-01 → 2023-09-30¥166m
jpcrp040300-q1r_E05367-000Functional Cosmetic Retailingreportable segmentrevenue external2023-07-01 → 2023-09-30¥166m
jpcrp040300-q1r_E05367-000Functional Cosmetic Retailingreportable segmentsegment profit2023-07-01 → 2023-09-30−¥148m
jpcrp040300-q1r_E05367-000Functional Food Retailingreportable segmentrevenue2023-07-01 → 2023-09-30¥677m
jpcrp040300-q1r_E05367-000Functional Food Retailingreportable segmentrevenue external2023-07-01 → 2023-09-30¥676m
jpcrp040300-q1r_E05367-000Functional Food Retailingreportable segmentrevenue intersegment2023-07-01 → 2023-09-30¥645,000
jpcrp040300-q1r_E05367-000Functional Food Retailingreportable segmentsegment profit2023-07-01 → 2023-09-30−¥267m
jpcrp040300-q1r_E05367-000Functional Material Developmentreportable segmentrevenue2023-07-01 → 2023-09-30¥71m
jpcrp040300-q1r_E05367-000Functional Material Developmentreportable segmentrevenue external2023-07-01 → 2023-09-30¥67m
jpcrp040300-q1r_E05367-000Functional Material Developmentreportable segmentrevenue intersegment2023-07-01 → 2023-09-30¥3m
jpcrp040300-q1r_E05367-000Functional Material Developmentreportable segmentsegment profit2023-07-01 → 2023-09-30−¥8m
jpcrp040300-q1r_E05367-000Health Care Support Servicereportable segmentrevenue2023-07-01 → 2023-09-30¥157m
jpcrp040300-q1r_E05367-000Health Care Support Servicereportable segmentrevenue external2023-07-01 → 2023-09-30¥157m
jpcrp040300-q1r_E05367-000Health Care Support Servicereportable segmentsegment profit2023-07-01 → 2023-09-30¥11m
—segment totalrevenue2023-07-01 → 2023-09-30¥1.1bn
—segment totalrevenue external2023-07-01 → 2023-09-30¥1.1bn
—segment totalrevenue intersegment2023-07-01 → 2023-09-30¥4m
—segment totalsegment profit2023-07-01 → 2023-09-30−¥423m
Reconciling Itemsreconcilingrevenue2022-07-01 → 2022-09-30¥600,000
Reconciling Itemsreconcilingrevenue external2022-07-01 → 2022-09-30¥600,000
Reconciling Itemsreconcilingsegment profit2022-07-01 → 2022-09-30−¥77m
jpcrp040300-q1r_E05367-000Clinical Evidence Servicereportable segmentrevenue2022-07-01 → 2022-09-30¥89m
jpcrp040300-q1r_E05367-000Clinical Evidence Servicereportable segmentrevenue external2022-07-01 → 2022-09-30¥89m
jpcrp040300-q1r_E05367-000Clinical Evidence Servicereportable segmentsegment profit2022-07-01 → 2022-09-30−¥13m
jpcrp040300-q1r_E05367-000Functional Cosmetic Retailingreportable segmentrevenue2022-07-01 → 2022-09-30¥1.1bn
jpcrp040300-q1r_E05367-000Functional Cosmetic Retailingreportable segmentrevenue external2022-07-01 → 2022-09-30¥1.1bn
jpcrp040300-q1r_E05367-000Functional Cosmetic Retailingreportable segmentsegment profit2022-07-01 → 2022-09-30¥282m
jpcrp040300-q1r_E05367-000Functional Food Retailingreportable segmentrevenue2022-07-01 → 2022-09-30¥732m
jpcrp040300-q1r_E05367-000Functional Food Retailingreportable segmentrevenue external2022-07-01 → 2022-09-30¥732m
jpcrp040300-q1r_E05367-000Functional Food Retailingreportable segmentsegment profit2022-07-01 → 2022-09-30−¥184m
jpcrp040300-q1r_E05367-000Functional Material Developmentreportable segmentrevenue2022-07-01 → 2022-09-30¥138m
jpcrp040300-q1r_E05367-000Functional Material Developmentreportable segmentrevenue external2022-07-01 → 2022-09-30¥138m
jpcrp040300-q1r_E05367-000Functional Material Developmentreportable segmentsegment profit2022-07-01 → 2022-09-30¥23m
jpcrp040300-q1r_E05367-000Health Care Support Servicereportable segmentrevenue2022-07-01 → 2022-09-30¥148m
jpcrp040300-q1r_E05367-000Health Care Support Servicereportable segmentrevenue external2022-07-01 → 2022-09-30¥148m
jpcrp040300-q1r_E05367-000Health Care Support Servicereportable segmentsegment profit2022-07-01 → 2022-09-30¥15m
—segment totalrevenue2022-07-01 → 2022-09-30¥2.2bn
—segment totalrevenue external2022-07-01 → 2022-09-30¥2.2bn
—segment totalsegment profit2022-07-01 → 2022-09-30¥123m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 310
ItemContextValueUnit
Capital surplusPrior1YearInstant1899955000JPY
Capital surplusCurrentQuarterInstant1899955000JPY
Retained earningsPrior1YearInstant3232312000JPY
Retained earningsCurrentQuarterInstant2574424000JPY
Shareholders equityPrior1YearInstant6968855000JPY
Shareholders equityCurrentQuarterInstant6310967000JPY
Non controlling interestsPrior1YearInstant203362000JPY
Non controlling interestsCurrentQuarterInstant202489000JPY
Net assetsPrior1YearInstant7172217000JPY
Net assetsCurrentQuarterInstant6513457000JPY
Liabilities and net assetsPrior1YearInstant8239982000JPY
Liabilities and net assetsCurrentQuarterInstant7415538000JPY
Net salesPrior1YTDDuration2216881000JPY
Net salesCurrentYTDDuration1124626000JPY
Cost of salesPrior1YTDDuration1160778000JPY
Cost of salesCurrentYTDDuration587927000JPY
Gross profitPrior1YTDDuration1056102000JPY
Gross profitCurrentYTDDuration536698000JPY
Selling general and administrative expensesPrior1YTDDuration1010156000JPY
Selling general and administrative expensesCurrentYTDDuration1037729000JPY
Operating incomePrior1YTDDuration45946000JPY
Operating incomeCurrentYTDDuration-501031000JPY
Interest income noiPrior1YTDDuration105000JPY
Interest income noiCurrentYTDDuration28000JPY
Compensation income noiPrior1YTDDuration143000JPY
Compensation income noiCurrentYTDDuration3647000JPY
Other noiPrior1YTDDuration820000JPY
Other noiCurrentYTDDuration1691000JPY
Non operating incomePrior1YTDDuration1069000JPY
Non operating incomeCurrentYTDDuration5367000JPY
Other noePrior1YTDDuration535000JPY
Other noeCurrentYTDDuration739000JPY
Non operating expensesPrior1YTDDuration535000JPY
Non operating expensesCurrentYTDDuration739000JPY
Ordinary incomePrior1YTDDuration46479000JPY
Ordinary incomeCurrentYTDDuration-496402000JPY
Loss on sales of noncurrent assets elPrior1YTDDuration-JPY
Loss on sales of noncurrent assets elCurrentYTDDuration134000JPY
Extraordinary lossPrior1YTDDuration-JPY
Extraordinary lossCurrentYTDDuration134000JPY
Income before income taxesPrior1YTDDuration46479000JPY
Income before income taxesCurrentYTDDuration-496537000JPY
Income taxes currentPrior1YTDDuration30022000JPY
Income taxes currentCurrentYTDDuration1024000JPY
Income taxes deferredPrior1YTDDuration529000JPY
Income taxes deferredCurrentYTDDuration30407000JPY
Income taxesPrior1YTDDuration30551000JPY
Income taxesCurrentYTDDuration31431000JPY
Profit lossPrior1YTDDuration15928000JPY
Profit lossCurrentYTDDuration-527969000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-06-30pass rounding
balance sheet identityconsolidated 2023-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-06-30pass
statement vs summary · net assetsconsolidated 2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-07-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-07-01/2023-09-30pass
statement vs summary · revenueconsolidated 2022-07-01/2022-09-30pass
statement vs summary · revenueconsolidated 2023-07-01/2023-09-30pass
statement vs summary · total assetsconsolidated 2023-06-30pass
statement vs summary · total assetsconsolidated 2023-09-30pass